Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1992 May;60(5):2023–2029. doi: 10.1128/iai.60.5.2023-2029.1992

Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine.

B D Forrest 1
PMCID: PMC257110  PMID: 1563793

Abstract

Intestinal fluid, saliva, circulating peripheral blood lymphocytes (PBL), and serum samples obtained from 81 human adult subjects who had been orally vaccinated with either Salmonella typhi Ty21a or one of its recombinant derivatives were examined to determine the value of indirect measurements of an antigen-specific intestinal-immunoglobulin A (IgA) response. Salivary IgA failed to provide consistent or correlative responses, and no evidence of a significant relationship was apparent with the intestinal-IgA responses. No significant correlation between the specific increase in responses in serum IgA and intestinal IgA was evident. While the magnitude of the serum IgG response significantly correlated with the intestinal-IgA response (P = 0.00064), it failed to detect 14.8% of the intestinal-IgA responses. The observation that 16.6% of the subjects had delayed serum IgA responses, with a peak occurring after day 23 compared with days 12 to 14, may have contributed to the inadequacy of the serum IgA response as a correlative indicator. The serum IgG responses in these subjects were also of a diminished magnitude. Specific IgA production by circulating PBL was found to be the most sensitive (92.6% response rate) and correlative (P = 0.00071) indicator of a specific intestinal-IgA immune response. However, its value in predicting protective efficacy is untried. These studies confirm that for the assessment of an enteric bacterial vaccine, determination of in vitro specific IgA production by circulating PBL may offer a single measurement of specific immunity which is as useful as serum and intestinal measurements combined.

Full text

PDF
2029

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allardyce R. A., Shearman D. J., McClelland D. B., Marwick K., Simpson A. J., Laidlaw R. B. Appearance of specific colostrum antibodies after clinical infection with Salmonella typhimurium. Br Med J. 1974 Aug 3;3(5926):307–309. doi: 10.1136/bmj.3.5926.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Attridge S. R., Dearlove C., Beyer L., van den Bosch L., Howles A., Hackett J., Morona R., LaBrooy J., Rowley D. Characterization and immunogenicity of EX880, a Salmonella typhi Ty21a-based clone which produces Vibrio cholerae O antigen. Infect Immun. 1991 Jul;59(7):2279–2284. doi: 10.1128/iai.59.7.2279-2284.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bartholomeusz R. C., Forrest B. D., Labrooy J. T., Ey P. L., Pyle D., Shearman D. J., Rowley D. The serum polymeric IgA antibody response to typhoid vaccination; its relationship to the intestinal IgA response. Immunology. 1990 Feb;69(2):190–194. [PMC free article] [PubMed] [Google Scholar]
  4. Chau P. Y., Tsang R. S., Lam S. K., La Brooy J. T., Rowley D. Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. II. Measurement of intestinal antibodies by radioimmunoassay. Clin Exp Immunol. 1981 Dec;46(3):515–520. [PMC free article] [PubMed] [Google Scholar]
  5. Clemens J. D., Jertborn M., Sack D., Stanton B., Holmgren J., Khan M. R., Huda S. Effect of neutralization of gastric acid on immune responses to an oral B subunit, killed whole-cell cholera vaccine. J Infect Dis. 1986 Jul;154(1):175–178. doi: 10.1093/infdis/154.1.175. [DOI] [PubMed] [Google Scholar]
  6. Clemens J. D., van Loon F., Sack D. A., Chakraborty J., Rao M. R., Ahmed F., Harris J. R., Khan M. R., Yunus M., Huda S. Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. J Infect Dis. 1991 Jun;163(6):1235–1242. doi: 10.1093/infdis/163.6.1235. [DOI] [PubMed] [Google Scholar]
  7. Czerkinsky C., Prince S. J., Michalek S. M., Jackson S., Russell M. W., Moldoveanu Z., McGhee J. R., Mestecky J. IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2449–2453. doi: 10.1073/pnas.84.8.2449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Forrest B. D. Identification of an intestinal immune response using peripheral blood lymphocytes. Lancet. 1988 Jan 16;1(8577):81–83. doi: 10.1016/s0140-6736(88)90284-x. [DOI] [PubMed] [Google Scholar]
  9. Forrest B. D., LaBrooy J. T., Attridge S. R., Boehm G., Beyer L., Morona R., Shearman D. J., Rowley D. Immunogenicity of a candidate live oral typhoid/cholera hybrid vaccine in humans. J Infect Dis. 1989 Jan;159(1):145–146. doi: 10.1093/infdis/159.1.145. [DOI] [PubMed] [Google Scholar]
  10. Forrest B. D., LaBrooy J. T., Beyer L., Dearlove C. E., Shearman D. J. The human humoral immune response to Salmonella typhi Ty21a. J Infect Dis. 1991 Feb;163(2):336–345. doi: 10.1093/infdis/163.2.336. [DOI] [PubMed] [Google Scholar]
  11. Forrest B. D., LaBrooy J. T., Dearlove C. E., Shearman D. J. Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a. Infect Immun. 1992 Feb;60(2):465–471. doi: 10.1128/iai.60.2.465-471.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Forrest B. D., LaBrooy J. T., Robinson P., Dearlove C. E., Shearman D. J. Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine. Infect Immun. 1991 Mar;59(3):1206–1209. doi: 10.1128/iai.59.3.1206-1209.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Forrest B. D., Shearman D. J., LaBrooy J. T. Specific immune response in humans following rectal delivery of live typhoid vaccine. Vaccine. 1990 Jun;8(3):209–212. doi: 10.1016/0264-410x(90)90047-p. [DOI] [PubMed] [Google Scholar]
  14. Forrest B. D. The development of a bivalent vaccine against diarrhoeal disease. Southeast Asian J Trop Med Public Health. 1988 Sep;19(3):449–457. [PubMed] [Google Scholar]
  15. Germanier R., Füer E. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis. 1975 May;131(5):553–558. doi: 10.1093/infdis/131.5.553. [DOI] [PubMed] [Google Scholar]
  16. Giannella R. A., Broitman S. A., Zamcheck N. Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective. Ann Intern Med. 1973 Feb;78(2):271–276. doi: 10.7326/0003-4819-78-2-271. [DOI] [PubMed] [Google Scholar]
  17. Gilman R. H., Hornick R. B., Woodard W. E., DuPont H. L., Snyder M. J., Levine M. M., Libonati J. P. Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis. 1977 Dec;136(6):717–723. doi: 10.1093/infdis/136.6.717. [DOI] [PubMed] [Google Scholar]
  18. Jertborn M., Svennerholm A. M., Holmgren J. Gut mucosal, salivary and serum antitoxic and antibacterial antibody responses in Swedes after oral immunization with B subunit-whole cell cholera vaccine. Int Arch Allergy Appl Immunol. 1984;75(1):38–43. doi: 10.1159/000233587. [DOI] [PubMed] [Google Scholar]
  19. Jertborn M., Svennerholm A. M., Holmgren J. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J Clin Microbiol. 1986 Aug;24(2):203–209. doi: 10.1128/jcm.24.2.203-209.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kantele A. Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. Vaccine. 1990 Aug;8(4):321–326. doi: 10.1016/0264-410x(90)90088-4. [DOI] [PubMed] [Google Scholar]
  21. Kantele A., Arvilommi H., Jokinen I. Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. J Infect Dis. 1986 Jun;153(6):1126–1131. doi: 10.1093/infdis/153.6.1126. [DOI] [PubMed] [Google Scholar]
  22. La Brooy J. T., Davidson G. P., Sherman D. J., Rowley D. The antibody response to bacterial gastroenteritis in serum and secretions. Clin Exp Immunol. 1980 Aug;41(2):290–296. [PMC free article] [PubMed] [Google Scholar]
  23. La Brooy J. T., Shearman D. J., Rowley D. Antibodies in serum and secretions 1 year after salmonella gastroenteritis. Clin Exp Immunol. 1982 Jun;48(3):551–554. [PMC free article] [PubMed] [Google Scholar]
  24. Levine M. M., Ferreccio C., Black R. E., Tacket C. O., Germanier R. Progress in vaccines against typhoid fever. Rev Infect Dis. 1989 May-Jun;11 (Suppl 3):S552–S567. doi: 10.1093/clinids/11.supplement_3.s552. [DOI] [PubMed] [Google Scholar]
  25. Levine M. M., Herrington D., Murphy J. R., Morris J. G., Losonsky G., Tall B., Lindberg A. A., Svenson S., Baqar S., Edwards M. F. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest. 1987 Mar;79(3):888–902. doi: 10.1172/JCI112899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Levine M. M., Kaper J. B., Herrington D., Ketley J., Losonsky G., Tacket C. O., Tall B., Cryz S. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet. 1988 Aug 27;2(8609):467–470. doi: 10.1016/s0140-6736(88)90120-1. [DOI] [PubMed] [Google Scholar]
  27. Levine M. M., Kaper J. B., Herrington D., Losonsky G., Morris J. G., Clements M. L., Black R. E., Tall B., Hall R. Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun. 1988 Jan;56(1):161–167. doi: 10.1128/iai.56.1.161-167.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mestecky J., McGhee J. R., Arnold R. R., Michalek S. M., Prince S. J., Babb J. L. Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest. 1978 Mar;61(3):731–737. doi: 10.1172/JCI108986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mestecky J., Russell M. W., Jackson S., Brown T. A. The human IgA system: a reassessment. Clin Immunol Immunopathol. 1986 Jul;40(1):105–114. doi: 10.1016/0090-1229(86)90073-5. [DOI] [PubMed] [Google Scholar]
  30. Migasena S., Pitisuttitham P., Prayurahong B., Suntharasamai P., Supanaranond W., Desakorn V., Vongsthongsri U., Tall B., Ketley J., Losonsky G. Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults. Infect Immun. 1989 Nov;57(11):3261–3264. doi: 10.1128/iai.57.11.3261-3264.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Nayak N., Ganguly N. K., Walia B. N., Wahi V., Kanwar S. S., Mahajan R. C. Specific secretory IgA in the milk of Giardia lamblia-infected and uninfected women. J Infect Dis. 1987 Apr;155(4):724–727. doi: 10.1093/infdis/155.4.724. [DOI] [PubMed] [Google Scholar]
  32. Naylor G. R. Incubation period and other features of food-borne and water-borne outbreaks of typhoid fever in relation to pathogenesis and genetics of resistance. Lancet. 1983 Apr 16;1(8329):864–866. doi: 10.1016/s0140-6736(83)91395-8. [DOI] [PubMed] [Google Scholar]
  33. Samson R. R., McClelland D. B., Shearman D. J. Studies on the quantitation of immunoglobulin in human intestinal secretions. Gut. 1973 Aug;14(8):616–626. doi: 10.1136/gut.14.8.616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Svennerholm A. M., Gothefors L., Sack D. A., Bardhan P. K., Holmgren J. Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes. Bull World Health Organ. 1984;62(6):909–918. [PMC free article] [PubMed] [Google Scholar]
  35. Svennerholm A. M., Sack D. A., Holmgren J., Bardhan P. K. Intestinal antibody responses after immunisation with cholera B subunit. Lancet. 1982 Feb 6;1(8267):305–308. doi: 10.1016/s0140-6736(82)91568-9. [DOI] [PubMed] [Google Scholar]
  36. Tacket C. O., Forrest B., Morona R., Attridge S. R., LaBrooy J., Tall B. D., Reymann M., Rowley D., Levine M. M. Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a. Infect Immun. 1990 Jun;58(6):1620–1627. doi: 10.1128/iai.58.6.1620-1627.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES